Drug Hunter

New York, United States Founded: 2014 • Age: 12 yrs
Information on drug discovery topics is delivered via online platform.

About Drug Hunter

Drug Hunter is a Healthcare company based in New York (United States) founded in 2014. Information on drug discovery topics is delivered via online platform. Drug Hunter has raised $6.79 million across 3 funding rounds from investors including Teamworthy Ventures. Its website drughunter.com draws about 53 thousand monthly visits. Drug Hunter offers products and services including Patent Search Tool, Molecule Highlights, and Clinical Updates. Its focus areas include HealthTech, Online Health Information, Internet First Media and Drugs. Its legal entity is Drug Hunter, Inc. Its competitors include ProQuest, Authorea and Research Solutions; 2 of its 3 listed competitors have raised funding.

Company details

Drug Hunter was established in 2014 in New York, United States, within the pharmaceutical information sector. An online platform is maintained to deliver details on drug discovery processes. Coverage includes molecular interactions, small molecule synthesis, drug lipophilicity, and regulatory approvals. Articles detailing specific molecules and their progression through pharmaceutical development are also presented to users.

Key Metrics
  • Total Equity Funding
    $6.79M (USD)

    in 3 rounds

  • Latest Funding Round
    $6.04M (USD), Seed

    Sep 2025

  • Investors

Products & Services of Drug Hunter

Drug Hunter offers a comprehensive portfolio of products and services, including Patent Search Tool, Molecule Highlights, and Clinical Updates.

Patent Search Tool
Research Platform

Service for searching and annotating drug-related patents

Molecule Highlights
Content Service

Features reviews of key drug molecules and their developments

Clinical Updates
Information Resource

Provides summaries of ongoing clinical trials and outcomes

Apps and channels of Drug Hunter

its YouTube channel Drug Hunter has 3.9K subscribers and 30 videos.

Drug Hunter
YouTube 3.9K subscribers 30 videos Science & Technology
Open channel

Videos from Drug Hunter

The most watched videos on Drug Hunter's YouTube channel, Drug Hunter (3.9K subscribers). Click a video to play it here.

AI-First Drug Design: Accelerating the Discovery of New Therapeutics
9.4K views
Applying Active Learning in Drug Discovery
3.8K views
The Chemist's Playbook: Impactful Bioisosteres for Modern Drug Design
3.4K views
Simplifying Synthesis with Radical Cross-Coupling
3.2K views

More on Drug Hunter.

Funding Insights of Drug Hunter

Drug Hunter has successfully raised a total of $6.79M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $6.04 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6.79M
  • Total Rounds 3
  • Last Round Seed β€” $6.04M
  • First Round $698,382

    (Jan 2023)

  • Investors Count 1

All 3 funding rounds of Drug Hunter with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2025$6.04MSeed–Teamworthy Ventures
–
Mar 2024$50,000Seed––
–
Jan 2023$698,382Seed––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Drug Hunter

Drug Hunter has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Teamworthy Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital is invested in consumer and enterprise software services.
teamworthy.comGreenwich, United States
Premium access

Investor details for Drug Hunter

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Drug Hunter

9 people are tracked at Drug Hunter (1 in leadership, 8 in board & advisors).

NameRoleGroup
Alex Schleifer
Chief Design OfficerLeadership
Amanda Yarnell
AdvisorBoard & advisors
Troy W. Young
AdvisorBoard & advisors
Wendy Young
ChairwomanBoard & advisors
Nick Sanchez
AdvisorBoard & advisors
Andres Ruiz
AdvisorBoard & advisors
Gary Yeung
AdvisorBoard & advisors
Matthew Sanchez
AdvisorBoard & advisors
Ben Slivka
AdvisorBoard & advisors
Premium access

Complete people profiles for Drug Hunter

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Drug Hunter

3 dated milestones of Drug Hunter across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Drug Hunter is founded.
  2. Funding First funding round of $698K.
  3. Funding Latest funding round, Seed, of $6.0M.

Competitors of Drug Hunter

Drug Hunter has 3 listed competitors in our database, 2 of them funded. They include ProQuest, Authorea and Research Solutions.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
proquest.com2008Ann Arbor, United States
Research content is delivered via online platforms to libraries.
authorea.com2012New York, United States$2.11M88
Collaborative platform for research and learning
researchsolutions.com2006Henderson, United States$12.06M34
AI-powered solutions for scholarly content access and management are provided.
Premium access

Detailed competitors of Drug Hunter

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Drug Hunter

The website of Drug Hunter (drughunter.com) receives about 52.6K visits a month.

  • Monthly visits
    52.6K

    ▲ 31.6% vs previous month

Similar websites

Websites whose visitors overlap most with Drug Hunter. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cambridgemedchemconsulting.com
cambridgemedchemconsulting.com
100%
#4,212,862–
drugdiscoverychemistry.com
drugdiscoverychemistry.com
100%
#2,221,272–
biochempeg.com
biochempeg.com
100%
#725,385–
americanpharmaceuticalreview.com
americanpharmaceuticalreview.com
100%
#730,834–
researchgate.net
66%
101.7M#345View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 15 similar websites and full traffic analytics for Drug Hunter

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Digital Health & Telemedicine

3 companies that operate in the same segment as Drug Hunter (Digital Health & Telemedicine) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
An application is provided for comparing prescription drug prices nationwide.
2011Santa Monica, California, United StatesUSD 22.21 MUSD 796.85 M1,063
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Alto Pharmacy is focused on providing convenient prescription delivery services.
2015San Francisco, California, United StatesUSD 591.64 M802
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Drug Hunter

Drug Hunter was founded in 2014 and raised its 1st funding round 9 years after it was founded.

Drug Hunter is headquartered in New York, United States. It is registered at New York, New York, United States.

Drug Hunter is a funded company, having raised a total of $6.79M across 3 funding rounds to date. The company's 1st funding round was a Seed of $698.38K, raised on Jan 2023.

Drug Hunter was established in 2014 in New York, United States, within the pharmaceutical information sector. An online platform is maintained to deliver details on drug discovery processes. Coverage includes molecular interactions, small molecule synthesis, drug lipophilicity, and regulatory approvals. Articles detailing specific molecules and their progression through pharmaceutical development are also presented to users.

Drug Hunter's top competitors include ProQuest, Research Solutions and Authorea.

Drug Hunter offers Patent Search Tool, Molecule Highlights, and Clinical Updates.

Drug Hunter has 1 investor. Key investors include Teamworthy Ventures.

Drug Hunter operates through Drug Hunter, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available